Skip to main content

Advertisement

Table 2 Updated/started Cochrane reviews as a result of NIHR HTA Grant (14/27/02) [49]

From: Study-based registers reduce waste in systematic reviewing: discussion and case report

Anticholinergic medication for antipsychotic-induced tardive dyskinesia [53]
Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia [54]
Benzodiazepines for antipsychotic-induced tardive dyskinesia [55]
Calcium channel blockers for antipsychotic-induced tardive dyskinesia [56]
Cholinergic medication for antipsychotic-induced tardive dyskinesia [57]
Gamma-aminobutyric acid agonists for antipsychotic-induced tardive dyskinesia [58]
Miscellaneous treatments for antipsychotic-induced tardive dyskinesia [59]
Non-antipsychotic catecholaminergic drugs for antipsychotic-induced tardive dyskinesia [60]
Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesiaa [61]
Vesicular monoamine transporter inhibitors versus placebo for antipsychotic-induced tardive dyskinesiab [62]
Vitamin E for antipsychotic-induced tardive dyskinesia [63]
  1. aThis review is absent in the published report [51] because there was no new study
  2. bThis review is absent in the published report [51] because we became informed and started this review as a result of update search process in SBR